My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Vedanta gains after board OKs fund raising
Nov 22,2016

The announcement was made during market hours today, 22 November 2016.

Meanwhile, the BSE Sensex was up 154.12 points, or 0.60%, to 25,919.26.

On BSE, so far 8.18 lakh shares were traded in the counter, compared with average daily volume of 11.33 lakh shares in the past one quarter. The stock hit a high of Rs 206.20 and a low of Rs 199.10 so far during the day. The stock hit a 52-week high of Rs 233.65 on 10 November 2016. The stock hit a 52-week low of Rs 58.10 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, falling 3.10% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.15% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 296.47 crore. Face value per share is Re 1.

Vedanta announced that it has received boards approval to raise Rs 300 crore through issue of 3,000 secured redeemable non-cumulative non-convertible debentures (NCDs) of face value of Rs 10 lakh each. The tenure of the NCDs is three years and five months from the date of allotment, while date of maturity is 22 April 2020. Crisil has assigned AA-/Stable rating to the said instrument.

In a separate announcement today, 22 November 2016, the company said that the board has approved the appointment of chief financial officer Arjun Kumar GR as a whole-time director of the company and Bhumika Sood as company secretary. The appointments reflect the focus of Vedanta towards empowering its professionals and developing in-house talent, said, Tom Albanese, CEO, Vedanta.

On a consolidated basis, Vedantas net profit rose 17.14% to Rs 1252.13 crore on 4.13% decline in net sales to Rs 15665.64 crore in Q2 September 2016 over Q2 September 2015.

Vedanta is a diversified natural resources company, whose business primarily involves producing oil & gas, zinc - lead - silver, copper, iron ore, aluminium and commercial power. The company has a presence across India, South Africa, Namibia, Australia and Ireland.

Powered by Capital Market - Live News

Shoppers Stop gains after opening of MAC store
Nov 22,2016

The announcement was made during market hours today, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 64.18 points or 0.25% at 25,829.32

Meanwhile, a bulk deal of 3 lakh shares was executed on the counter at Rs 295 per share at 09:51 IST on BSE. Bulk deal boosted volume on the Shoppers Stop scrip. On BSE, so far 3.42 lakh shares were traded in the counter as against average daily volume of 933 shares in the past one quarter. The stock hit a high of Rs 301 and a low of Rs 292 so far during the day. The stock hit a 52-week high of Rs 422 on 23 December 2015. The stock hit a 52-week low of Rs 290.15 on 21 November 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 19.59% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, declining 19.54% as against Sensexs 7.95% decline.

The small-cap company has an equity capital of Rs 41.75 crore. Face value per share is Rs 5.

With the opening of the latest store, the company has now 41 MAC doors under its operations, Shoppers Stop said. MAC stands for Make-up Art Cosmetics. MAC is a leading brand of professional cosmetics, created in Toronto, Canada in 1984 to support the special needs of professional makeup artists - a collection of colors, products and tools that meet the demanding lighting and studio conditions under which the pros work.

Shoppers Stops net profit fell 11.06% to Rs 10.69 crore on 7.14% growth in net sales to Rs 939.53 crore in Q2 September 2016 over Q2 September 2015.

Shoppers Stop runs department stores that sell apparel, cosmetics and fashion accessories.

Powered by Capital Market - Live News

Shoppers Stop gains after opening of M.A.C store
Nov 22,2016

With the opening of the latest store, the company has now 41 M.A.C doors under its operations, Shoppers Stop said. The announcement was made during market hours today, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 64.18 points or 0.25% at 25,829.32

Meanwhile, a bulk deal of 3 lakh shares was executed on the counter at Rs 295 per share at 09:51 IST on BSE. Bulk deal boosted volume on the Shoppers Stop scrip. On BSE, so far 3.42 lakh shares were traded in the counter as against average daily volume of 933 shares in the past one quarter. The stock hit a high of Rs 301 and a low of Rs 292 so far during the day. The stock hit a 52-week high of Rs 422 on 23 December 2015. The stock hit a 52-week low of Rs 290.15 on 21 November 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 19.59% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, declining 19.54% as against Sensexs 7.95% decline.

The small-cap company has an equity capital of Rs 41.75 crore. Face value per share is Rs 5.

Shoppers Stops net profit fell 11.06% to Rs 10.69 crore on 7.14% growth in net sales to Rs 939.53 crore in Q2 September 2016 over Q2 September 2015.

Shoppers Stop runs department stores that sell apparel, cosmetics and fashion accessories.

Powered by Capital Market - Live News

Shalimar Paints jumps on bargain hunting
Nov 22,2016

Meanwhile, the BSE Sensex was up 57.51 points, or 0.22%, to 25,822.65.

On BSE, so far 23,000 shares were traded in the counter, compared with average daily volume of 47,645 shares in the past one quarter. The stock hit a high of Rs 129 and a low of Rs 120.20 so far during the day. The stock hit a record high of Rs 223.60 on 23 August 2016. The stock hit a 52-week low of Rs 88.70 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 38.50% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 41.07% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 3.79 crore. Face value per share is Rs 2.

Shalimar Paints announced during market hours yesterday, 21 November 2016, that there has been a fire accident in one of the plants of the company at Gonde Dumala village, Igatpuri, Nasik on 19 November 2016. There has been no loss or injury to human life. The company is in the process of ascertaining the actual loss caused by the fire and also is in process of informing the same to the insurance company, Shalimar Paints said. The company is taking adequate steps to ensure re-functioning of the plant at the earliest, it said.

Following the announcement, shares of Shalimar Paints slumped 15.02% to Rs 121.40 yesterday, 21 November 2016.

Shalimar Paints net profit rose 95.97% to Rs 2.43 crore on 0.11% increase in total income to Rs 103.15 crore in Q2 September 2016 over Q2 September 2015.

Shalimar Paints is Indias iconic paint-maker. Established in 1902, the countrys first paint company is a pioneer in the field of paints and coatings.

Powered by Capital Market - Live News

Volumes jump at Shoppers Stop counter
Nov 22,2016

Shoppers Stop clocked volume of 3.42 lakh shares by 13:43 IST on BSE, a 586.92-times surge over two-week average daily volume of 1,000 shares. The stock rose 1.44% to Rs 298.60.

Wim Plast notched up volume of 12.24 lakh shares, a 258.90-fold surge over two-week average daily volume of 5,000 shares. The stock rose 1.3% to Rs 1,415. A large bulk deal of 12.01 lakh shares was executed on the scrip at Rs 1,370 per share in early trade on BSE.

UPL saw volume of 6.22 lakh shares, a 6.67-fold surge over two-week average daily volume of 93,000 shares. The stock dropped 2.71% to Rs 591.50.

Kotak Mahindra Bank clocked volume of 5.49 lakh shares, a 2.75-fold surge over two-week average daily volume of 2 lakh shares. The stock rose 0.23% to Rs 764.25.

Castrol India saw volume of 2.27 lakh shares, a 1.92-fold rise over two-week average daily volume of 1.18 lakh shares. The stock rose 0.3% to Rs 386.

Powered by Capital Market - Live News

Bliss GVS Pharma sweetens after overseas order win
Nov 22,2016

The announcement was made during market hours today, 22 November 2016.

Meanwhile, the S&P BSE Sensex was up 58.85 points or 0.23% at 25,823.99

On BSE, so far 1.05 lakh shares were traded in the counter as against average daily volume of 1.03 lakh shares in the past one quarter. The stock hit a high of Rs 125.80 and a low of Rs 117.50 so far during the day. The stock had hit a 52-week high of Rs 201.30 on 27 November 2015. The stock had hit a 52-week low of Rs 79 on 17 June 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 24.03% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, declining 11.12% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 10.31 crore. Face value per share is Re 1.

Bliss GVS Healthcare, the Kenyan step down subsidiary of Bliss GVS Pharma, has won a three year contract worth $111.40 million from Aon Kenya Insurance Brokers, for provision of Medical Healthcare Services in Kenya. This contract covers outpatient services for over 3.04 lakh members. This medical cover is to be managed by Aon Kenya Insurance Brokers will benefit the principle contributor, his/her spouse and up to four children, the company said.

Bliss GVS Pharma said the medical cover provides for dental, optical on an out-patient basis and for maternity. The service payments will be received by the company from Aon, in advance, on a quarterly basis, the company said. Part payment for the first quarter payment has been received by the company, it added.

Bliss GVS Pharmas consolidated net profit fell 40.76% to Rs 13.65 crore on 6.72% decline in total income to Rs 171.35 crore in Q2 September 2016 over Q2 September 2015.

Bliss GVS Pharma is a fast-growing pharmaceutical company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.

Powered by Capital Market - Live News

RattanIndia Infra slips after Morgan Stanley pares stake
Nov 22,2016

Meanwhile, the BSE Sensex was up 34.86 points, or 0.14%, to 25,800.

On BSE, so far 85,000 shares were traded in the counter, compared with average daily volume of 4.49 lakh shares in the past one quarter. The stock hit a high of Rs 2.99 and a low of Rs 2.85 so far during the day. The stock hit a 52-week high of Rs 4.34 on 12 May 2016. The stock hit a 52-week low of Rs 2.85 on 22 November 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 8.84% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 16.25% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 276.45 crore. Face value per share is Rs 2.

As on 30 September 2016, Morgan Stanley Asia (Singapore) held 2.24 crore shares, or 1.626% stake, of RattanIndia Infrastructure.

RattanIndia Infrastructure reported net loss of Rs 1.64 crore in Q1 June 2016 as against net loss of Rs 0.12 crore in Q1 June 2015. There were no sales reported in Q1 June 2016 and in Q1 June 2015.

Powered by Capital Market - Live News

Wim Plast advances after large bulk deal
Nov 22,2016

Meanwhile, the S&P BSE Sensex was up 56.05 points, or 0.22%, to 25,821.19

Bulk deal boosted volume on the scrip. On BSE, so far 12.23 lakh shares were traded in the counter, compared with average daily volume of 3,964 shares in the past one quarter. The stock hit a high of Rs 1,540 and a low of Rs 1,320 so far during the day. The stock hit a record high of Rs 1,660 on 8 November 2016. The stock hit a 52-week low of Rs 775.50 on 1 April 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, falling 4.39% compared with the 8.23% decline in the Sensex. The scrip also outperformed the market in past one quarter, gaining 12% as against Sensexs 7.95% decline.

The small-cap company has an equity capital of Rs 12 crore. Face value per share is Rs 10.

Wim Plasts consolidated net profit rose 5.18% to Rs 9.13 crore on 4.88% fall in total income to Rs 77.69 crore in Q2 September 2016 over Q2 September 2015.

Wim Plast manufactures plastic moulded furnitures.

Powered by Capital Market - Live News

L&T slips ahead of Q2 results
Nov 22,2016

Meanwhile, the BSE Sensex was up 48.21 points, or 0.19%, to 25,813.35.

On BSE, so far 1.05 lakh shares were traded in the counter, compared with average daily volume of 2.55 lakh shares in the past one quarter. The stock hit a high of Rs 1,360 and a low of Rs 1,306.60 so far during the day. The stock hit a 52-week high of Rs 1,615 on 27 July 2016. The stock hit a 52-week low of Rs 1,016.60 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, sliding 10.74% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 8.63% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 186.47 crore. Face value per share is Rs 2.

L&T announced during trading hours today, 22 November 2016, that its construction arm has won orders worth Rs 1926 crore across its various business segments.

L&Ts consolidated net profit rose 45.5% to Rs 609.60 crore on 9.3% growth in net sales to Rs 21718.61 crore in Q1 June 2016 over Q1 June 2015.

L&T is a major Indian multinational engaged in technology, engineering, construction, manufacturing and financial services. It operates in more than 30 countries worldwide.

Powered by Capital Market - Live News

Sobha hits 52-week low after poor Q2 result
Nov 22,2016

The result was announced after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 80.09 points, or 0.31%, to 25,845.23

On BSE, so far 9,547 shares were traded in the counter, compared with average daily volume of 13,180 shares in the past one quarter. The stock hit a high of Rs 234.05 so far during the day. The stock hit a low of Rs 224.05 in intraday trade so far, which is 52-week low for the counter. The stock hit a 52-week high of Rs 346 on 26 July 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 18.44% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, sliding 18.25% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 98.06 crore. Face value per share is Rs 10.

In Q2 September 2016, Sobha achieved new sales of 8.55 lakh square feet, valued at Rs 551 crore with an average realisation of Rs 6443 per square feet (Sobhas share of sale value stood at Rs 518 crore with an average realisation of Rs 6056 per square feet).

J.C. Sharma, Vice Chairman and Managing Director, Sobha said that the company has seen consistent improvement in cash flow and generated net positive operational cash flow for the past five consecutive quarters.

Sobha is a backward integrated real estate player. The company is primarily focused on residential and contractual projects.

Powered by Capital Market - Live News

Panacea Biotec gains over 3% in two sessions
Nov 22,2016

The announcement was made during market hours yesterday, 21 November 2016. Shares of Panacea Biotec rose 2.32% to Rs 107.95 on that day. The stock has risen 3.32% in two trading sessions from its close of Rs 105.50 on 18 November 2016.

Meanwhile, the BSE Sensex was up 100.04 points, or 0.39%, to 25,865.18.

On BSE, so far 2,493 shares were traded in the counter, compared with average daily volume of 14,290 shares in the past one quarter. The stock hit a high of Rs 111.85 and a low of Rs 108.60 so far during the day. The stock hit a 52-week high of Rs 171.20 on 4 December 2015. The stock hit a 52-week low of Rs 83.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, rising 0.47% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, falling 1.51% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Rs 1.

Panacea Biotec has state-of-the-art pharmaceutical formulation facility located at Baddi for oral solids and oncology parenteral formulations. The company has been supplying products in US markets for approved abbreviated new drug applications (ANDAs) manufactured in oral solids dosage facility. A number of ANDAs submitted by the company, referring these facilities, are also at various stages of approval by the United States Food and Drug Administration (USFDA).

Panacea Biotec reported net loss of Rs 11.84 crore in Q2 September 2016, lower than net loss of Rs 17 crore in Q2 September 2015. Net sales declined 18.3% to Rs 131.56 crore in Q2 September 2016 over Q2 September 2015.

Panacea Biotec is one of Indias leading research based health management companies with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers in India and is one of the leading biotechnology companies.

Powered by Capital Market - Live News

Vedanta firms up ahead of board meeting
Nov 22,2016

Meanwhile, the BSE Sensex was up 119.70 points, or 0.46%, to 25,884.84.

On BSE, so far 4.06 lakh shares were traded in the counter, compared with average daily volume of 11.33 lakh shares in the past one quarter. The stock hit a high of Rs 204.85 and a low of Rs 199.10 so far during the day. The stock hit a 52-week high of Rs 233.65 on 10 November 2016. The stock hit a 52-week low of Rs 58.10 on 12 February 2016. The stock had outperformed the market over the past 30 days till 21 November 2016, falling 3.10% compared with the 8.23% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.15% as against Sensexs 7.95% decline.

The large-cap company has equity capital of Rs 296.47 crore. Face value per share is Re 1.

On a consolidated basis, Vedantas net profit rose 17.14% to Rs 1252.13 crore on 4.13% decline in net sales to Rs 15665.64 crore in Q2 September 2016 over Q2 September 2015.

Vedanta is a diversified natural resources company, whose business primarily involves producing oil & gas, zinc - lead - silver, copper, iron ore, aluminium and commercial power. The company has a presence across India, South Africa, Namibia, Australia and Ireland.

Powered by Capital Market - Live News

Suven Life Sciences in pink of health after securing two product patents
Nov 22,2016

The announcement was made during trading hours today, 22 November 2016.

Meanwhile, the BSE Sensex was up 99.64 points, or 0.39%, to 25,864.78

On BSE, so far 13,000 shares were traded in the counter, compared with average daily volume of 70,299 shares in the past one quarter. The stock hit a high of Rs 170 and a low of Rs 165.50 so far during the day. The stock hit a 52-week high of Rs 275.20 on 29 December 2015. The stock hit a 52-week low of Rs 144.35 on 19 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 16.28% compared with the 8.23% decline in the Sensex. The scrip also underperformed the market in past one quarter, sliding 16.32% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced the grant of one product patent from China and one product patent from Mexico corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2032 and 2031 respectively. The granted claims of the patents are from the mechanism of action include the class of selective H3 inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven Life Sciences said that the company has a total of twenty one granted patents from China and twenty two granted patents from Mexico. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts, the company said. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II, it added.

Suven Life Sciences net profit rose 58.2% to Rs 32.58 crore on 31.7% rise in net sales to Rs 133.23 crore in Q1 June 2016 over Q1 June 2015.

Suven Life Sciences is a biopharmaceutical company specializing in drug discovery and developmental activities in central nervous system disorders and contract research and manufacturing services (CRAMS).

Powered by Capital Market - Live News

Asian Oilfield Services jumps after winning contracts from Oil India
Nov 22,2016

The announcement was made after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 178.26 points, or 0.69%, to 25,943.40.

On BSE, so far 72,000 shares were traded in the counter, compared with average daily volume of 97,910 shares in the past one quarter. The stock hit a 52-week high of Rs 89.80 on 25 October 2016. The stock hit a 52-week low of Rs 27.90 on 12 February 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 13.63% compared with the 8.23% decline in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 2.49% as against Sensexs 7.95% decline.

The small-cap company has equity capital of Rs 22.32 crore. Face value per share is Rs 10.

Asian Oilfield Services said it received letters of award of two contracts by Oil India for acquisition of 2D Seismic Data in unappraised on land areas of North East India for an estimated total value of Rs 140 crore for both the contracts.

On a consolidated basis, Asian Oilfield Services reported net loss of Rs 11.12 crore in Q2 September 2016 as against net profit of Rs 4.09 crore in Q2 September 2015. Net sales declined 94.72% to Rs 3.09 crore in Q2 September 2016 over Q2 September 2015.

Asian Oilfield Services is engaged in providing geophysical, drilling and well services to customers across the Indian sub-continent.

Powered by Capital Market - Live News

AXIS Bank gains on fund raising plan
Nov 22,2016

The announcement was made after market hours yesterday, 21 November 2016.

Meanwhile, the BSE Sensex was up 232.51 points, or 0.90%, to 25,997.65.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 7.01 lakh shares in the past one quarter. The stock hit a high of Rs 471 and a low of Rs 467.90 so far during the day. The stock hit a 52-week high of Rs 638 on 7 September 2016. The stock hit a 52-week low of Rs 366.65 on 18 January 2016. The stock had underperformed the market over the past 30 days till 21 November 2016, falling 11.54% compared with the 8.23% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 20% as against Sensexs 7.95% decline.

The large-cap private sector bank has equity capital of Rs 478.17 crore. Face value per share is Rs 2.

AXIS Bank said it proposes to raise funds by issuing unsecured redeemable non-convertible subordinated debentures (Basel- III compliant Tier II debentures) (Series - 25) of the face value of Rs 10 lakh each for cash at par aggregating to Rs 1800 crore. The board of directors of the bank will consider the proposal to issue and allot the above securities through circular resolution.

Axis Banks net profit declined 83.3% to Rs 319.08 crore on 14.1% growth in operating income to Rs 13698.77 crore in Q2 September 2016 over Q2 September 2015.

Axis Bank is one of the biggest private sector banks in India.

Powered by Capital Market - Live News